Beta Bionics Shares Outstanding History (BBNX)
Beta Bionics reported 44.4M shares outstanding at the end of fiscal 2025.
View full Beta Bionics company overviewBeta Bionics annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 44.4M | 37.7M | +565.30% |
| 2024 | 2024-12-31 | 6.7M | −36.2M | −84.44% |
| 2023 | 2023-12-31 | 42.9M | 0 | 0.00% |
| 2022 | 2022-12-31 | 42.9M | — | — |
Beta Bionics quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 45.0M | 1.5M | +3.49% |
| Q1 2026 | 2026-03-31 | 44.6M | 1.2M | +2.79% |
| Q4 2025 | 2025-12-31 | 44.4M | 37.7M | +565.30% |
| Q3 2025 | 2025-09-30 | 44.0M | — | — |
| Q2 2025 | 2025-06-30 | 43.5M | — | — |
| Q1 2025 | 2025-03-31 | 43.4M | — | — |
| Q4 2024 | 2024-12-31 | 6.7M | — | — |
Beta Bionics shares outstanding trends
Between the periods ended 2022-12-31 and 2025-12-31, Beta Bionics's shares outstanding moved from 42.9M to 44.4M, a change of 1.5M. The latest reported quarter, Q2 2026, shows 45.0M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when a stock-split conversion ratio is reported directly or evidenced by a later filing’s restated historical share balance. After repeated reverse splits, an old period can represent less than one current-basis share; this is a split-adjusted equivalent, not a literal historical certificate count. Values remain as reported when no reliable split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Beta Bionics source filings ↗